Clinical performance evaluation of HCV and HIV-1 assays on the fully automated molecular system Alinity m

Kaplan, 2020, Hepatitis C virus review, Ann. Intern. Med., 173, ITC33, 10.7326/AITC202009010 Goldschmidt, 2021, HIV infection in adults: initial management, Am. Fam. Phys., 103, 407 Maartens, 2014, HIV infection: epidemiology, pathogenesis, treatment, and prevention, Lancet, 384, 258, 10.1016/S0140-6736(14)60164-1 Guss, 2018, Diagnosis and management of hepatitis C infection in primary care settings, J. Gen. Intern. Med., 33, 551, 10.1007/s11606-017-4280-y Nichols, 2019, Monitoring viral load for the last mile: what will it cost?, J. Int. AIDS Soc., 22, e25337, 10.1002/jia2.25337 van Belkum, 2023, Molecular diagnostics in medical microbiology: yesterday, today and tomorrow, Curr. Opin. Pharmacol., 3, 497, 10.1016/S1471-4892(03)00108-5 Scagnolari, 2017, Consolidation of molecular testing in clinical virology, Expert. Rev. Anti Infect. Ther., 15, 387, 10.1080/14787210.2017.1271711 Bourbeau, 2013, Automation in clinical microbiology, J. Clin. Microbiol., 51, 1658, 10.1128/JCM.00301-13 Croxatto, 2016, Laboratory automation in clinical bacteriology: what system to choose?, Clin. Microbiol. Infect., 22, 217, 10.1016/j.cmi.2015.09.030 Mouna, 2020, Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples, J. Clin. Virol., 126, 10.1016/j.jcv.2020.104331 Braun, 2020, Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance, J. Clin. Virol., 129, 10.1016/j.jcv.2020.104530 Galindo, 2021, Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory, J. Clin. Virol., 90